Burden and health care resource utilization in neovascular age-related macular degeneration -: Findings of a multicountry study

被引:114
|
作者
Soubrane, Gisele
Cruess, Alan
Lotery, Andrew
Pauleikhoff, Daniel
Mones, Jordi
Xu, Xiao
Zlateva, Gergana
Buggage, Ronald
Conlon, John
Goss, Thomas F.
机构
[1] Univ Paris 12, Dept Ophthalmol, Ctr Hosp Intercommunal, Creteil, France
[2] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada
[3] Univ Southampton, Div Clin Neurosci, Southampton, Hants, England
[4] St Franziskus Hosp, Dept Ophthalmol, Munster, Germany
[5] Inst Microcirugia Ocular Barcelona, Barcelona, Spain
[6] Covance Market Access Serv Inc, Gaithersburg, MD USA
[7] Pfizer Ophthalm, New York, NY USA
[8] Covance Inc, Princeton, NJ USA
关键词
D O I
10.1001/archopht.125.9.1249
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall wellbeing, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P <. 001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P <. 001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P <. 001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 50 条
  • [31] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [32] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [33] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Igwe, Chinedu
    Jackson, Timothy L.
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (08):
  • [34] An epidemiological study of neovascular age-related macular degeneration in Germany
    Krause, Lothar
    Yousif, Tarik
    Pohl, Karin
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1391 - 1397
  • [35] Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
    Van Cleemput, Liesbeth
    Peeters, Freya
    Jacob, Julie
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1077 - 1085
  • [36] Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD)
    Khanna, Saira
    Komati, Rahul
    Eichenbaum, David Aaron
    Hariprasad, Ishani
    Ciulla, Thomas A.
    Hariprasad, Seenu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [37] The Burden of Age-Related Macular Degeneration
    Jordana K. Schmier
    Mechelle L. Jones
    Michael T. Halpern
    PharmacoEconomics, 2006, 24 : 319 - 334
  • [38] The burden of age-related macular degeneration
    Schmier, JK
    Jones, ML
    Halpern, MT
    PHARMACOECONOMICS, 2006, 24 (04) : 319 - 334
  • [39] A Global Survey on Barriers to Care in Neovascular Age-Related Macular Degeneration
    Kamel, Kerollos
    Choi, Alison
    Nawash, Baraa
    Ong, Joshua
    Chhablani, Jay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [40] THE BURDEN OF DISEASE OF DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN COSTA RICA
    Hidalgo, J.
    Ordonez, J.
    Salas, M.
    Wu, L.
    Acevedo, R.
    Gutierrez, J. C.
    VALUE IN HEALTH, 2023, 26 (06) : S115 - S115